Immunoglobulin Market Size 2020 | North America, Europe & Asia Pacific Regions to Dominate the Global Industry

Rising at a CAGR of 7.0% between 2018 and 2025, the global immunoglobulins market is forecast to remain strong through the forecast period. Fortune Business Insights in a report, titled “IMMUNOGLOBULINS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025” states that the global market was worth US$ 10,750.0 Mn in 2017. The market is further expected to reach US$ 18,378.0 Mn by the end of 2025.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunoglobulins-market-100571

Leading Players operating in the Immunoglobulin Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• CSL Behring
• Grifols, S.A.
• Kedrion S.p.A
• Octapharma
• Bio Products Laboratory Ltd.
• Biotest AG
• China Biologic Products Holdings, Inc.
• LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Pipeline Analysis
4.2. Overview of Regulatory Scenario by Key Regions
4.3. Key Industry Developments
4.4. Number of Primary Immunodeficiency (PI) Patients by Key Countries
4.5. Overview of Reimbursement Scenario
5. Global Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Route of Administration
5.2.1. Intravenous (IV)
5.2.2. Subcutaneous (SC)
5.3. Market Analysis, Insights and Forecast – By Indication
5.3.1. Primary Immunodeficiency
5.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.3.3. Guillain-Barré Syndrome (GBS)
5.3.4. Immune Thrombocytopenic Purpura (ITP)
5.3.5. Multifocal Motor Neuropathy (MMN)
5.3.6. Others
5.4. Market Analysis, Insights and Forecast – By Form
5.4.1. Liquid
5.4.2. Lyophilized
5.5. Market Analysis, Insights and Forecast – By End User
5.5.1. Hospitals
5.5.2. Clinics
5.5.3. Homecare
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Route of Administration
6.2.1. Intravenous (IV)
6.2.2. Subcutaneous (SC)
6.3. Market Analysis – By Indication
6.3.1. Primary Immunodeficiency
6.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
6.3.3. Guillain-Barré Syndrome (GBS)
6.3.4. Immune Thrombocytopenic Purpura (ITP)
6.3.5. Multifocal Motor Neuropathy (MMN)
6.3.6. Others
6.4. Market Analysis – By Form
6.4.1. Liquid
6.4.2. Lyophilized
6.5. Market Analysis – By End User
6.5.1. Hospitals
6.5.2. Clinics
6.5.3. Homecare
6.6. Market Analysis – By Country
6.6.1. U.S.
6.6.2. Canada
7. Europe Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Route of Administration
7.2.1. Intravenous (IV)
7.2.2. Subcutaneous (SC)
7.3. Market Analysis – By Indication
7.3.1. Primary Immunodeficiency
7.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
7.3.3. Guillain-Barré Syndrome (GBS)
7.3.4. Immune Thrombocytopenic Purpura (ITP)
7.3.5. Multifocal Motor Neuropathy (MMN)
7.3.6. Others
7.4. Market Analysis – By Form
7.4.1. Liquid
7.4.2. Lyophilized
7.5. Market Analysis – By End User
7.5.1. Hospitals
7.5.2. Clinics
7.5.3. Homecare
7.6. Market Analysis – By Country/ Sub-Region
7.6.1. U.K.
7.6.2. Germany
7.6.3. France
7.6.4. Spain
7.6.5. Italy
7.6.6. Scandinavia
7.6.7. Rest of Europe
8. Asia Pacific Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Route of Administration
8.2.1. Intravenous (IV)
8.2.2. Subcutaneous (SC)
8.3. Market Analysis – By Indication
8.3.1. Primary Immunodeficiency
8.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
8.3.3. Guillain-Barré Syndrome (GBS)
8.3.4. Immune Thrombocytopenic Purpura (ITP)
8.3.5. Multifocal Motor Neuropathy (MMN)
8.3.6. Others
8.4. Market Analysis – By Form
8.4.1. Liquid
8.4.2. Lyophilized
8.5. Market Analysis – By End User
8.5.1. Hospitals
8.5.2. Clinics
8.5.3. Homecare
8.6. Market Analysis – By Country/ Sub-Region
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. Australia
8.6.5. Southeast Asia
8.6.6. Rest of Asia Pacific
Continued...
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunoglobulins-market-100571
Market Segmentation:
By Route of Administration
• Intravenous (IV)
• Subcutaneous (SC)
By Indication
• Primary Immunodeficiency
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Guillain-Barré Syndrome (GBS)
• Immune Thrombocytopenic Purpura (ITP)
• Multifocal Motor Neuropathy (MMN)
• Others
By Form
• Liquid
• Lyophilized
By End User
• Hospitals
• Clinics
• Homecare
By Geography
• North America (the U.S., and Canada)
• Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America
• Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Reasons to Purchase this Report:

• Comprehensive analysis of the Immunoglobulin Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.